Search Results - "Brus, Christina"

A Multidisciplinary Approach for Bone Metastases by Mori, Masanori, MD, Brus, Christina, MD, Bhatia, Avnish, MD, Nishihori, Taiga, MD, Blum, Ronald, MD

Get full text

U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review by Arora, Shaily, Narayan, Preeti, Osgood, Christy L, Wedam, Suparna, Prowell, Tatiana M, Gao, Jennifer J, Shah, Mirat, Krol, Danielle, Wahby, Sakar, Royce, Melanie, Ghosh, Soma, Philip, Reena, Ison, Gwynn, Berman, Tara, Brus, Christina, Bloomquist, Erik W, Fiero, Mallorie H, Tang, Shenghui, Pazdur, Richard, Ibrahim, Amna, Amiri-Kordestani, Laleh, Beaver, Julia A

“…Over the last decade, the treatment of patients with breast cancer has been greatly impacted by the approval of multiple drugs and indications. This summary…”
Get full text

A phase II study of palbociclib (PD-0332991) in adult patients with advanced hepatocellular carcinoma by Littman, Susan Joy, Brus, Christina, Burkart, Ashlie

“…Abstract only 277 Background: The oral MKI sorafenib has been shown to significantly increase PFS, OS and DCR in treatment-naïve HCC in randomized Ph 3 trials…”
Get full text

U.S. FDA Drug Approvals for Gynecological Malignancies: A Decade in Review by Arora, Shaily, Narayan, Preeti, Ison, Gwynn, Berman, Tara, Suzman, Daniel L, Wedam, Suparna, Prowell, Tatiana M, Ghosh, Soma, Philip, Reena, Osgood, Christy L, Gao, Jennifer J, Shah, Mirat, Krol, Danielle, Wahby, Sakar, Royce, Melanie, Brus, Christina, Bloomquist, Erik W, Fiero, Mallorie H, Tang, Shenghui, Pazdur, Richard, Ibrahim, Amna, Amiri-Kordestani, Laleh, Beaver, Julia A

“…Over the last decade, there has been tremendous progress in the treatment of patients with gynecologic cancers with a changing therapy landscape. This summary…”
Get full text

An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate by Devlin, Phillip M, Brus, Christina R, Kazakin, Julia, Mitchell, Ronald B, Demanes, D Jeffrey, Edmundson, Gregory, Gribble, Michael, Gustafson, Gary S, Kelly, Douglas A, Linares, Luis A, Martinez, Alvaro A, Mate, Timothy P, Nag, Subir, Perez, Carlos A, Rao, Jaynath G, Rodriguez, Rodney R, Shasha, Daniel, Tripuraneni, Prabhakar

“…To demonstrate a new interactive Internet-ready database for prospective clinical trials in high-dose-rate (HDR) brachytherapy for prostate cancer. An…”
Get more information

A phase II study of PD-0332991 in patients with advanced hepatocellular cancer by Littman, Susan Joy, Knudsen, Erik S., Witkiewicz, Agnieszka, Hyslop, Terry, Lewis, Nancy, Pillai, Madhavan V., Brus, Christina, Mitchell, Edith P.

“…Abstract only 321 Background: Hepatocellular carcinoma (HCC) is the 5th most common cancer worldwide and the 3rd most frequent cause of cancer-related…”
Get full text

Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010 by Brus, Christina, Saif, Muhammad Wasif

“…Most patients with adenocarcinoma of the pancreas present with locally advanced or metastatic disease. Although single agent gemcitabine is widely accepted as…”
Get full text